113
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder

, ORCID Icon, , &
Pages 671-687 | Received 13 Oct 2023, Accepted 28 Feb 2024, Published online: 27 Mar 2024

References

  • Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336–346. doi:10.1001/jamapsychiatry.2017.4602
  • Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–583. doi:10.1016/s0006-3223(02)01866-8
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Publishing; 2013.
  • Kroenke K, Spitzer RL, Williams JB. The PHQ‐9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x
  • Martin A, Rief W, Klaiberg A, Braehler E. Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2006;28(1):71–77. doi:10.1016/j.genhosppsych.2005.07.003
  • Allgaier A-K, Pietsch K, Frühe B, Sigl-Glöckner J, Schulte-Körne G. screening for depression in adolescents: validity of the patient health questionnaire in pediatric care. Depression and Anxiety. 2012;29(10):906–913. doi:10.1002/da.21971
  • Arthurs E, Steele RJ, Hudson M, Baron M, Thombs BD, Group CSR. Are scores on English and French versions of the PHQ-9 comparable? An assessment of differential item functioning. PLoS One. 2012;7(12):e52028. doi:10.1371/journal.pone.0052028
  • Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry. 2008;8(1):1–7. doi:10.1186/1471-244X-8-46
  • Miller AP, Espinosa da Silva C, Ziegel L, et al. Construct validity and internal consistency of the patient health questionnaire-9 (PHQ-9) depression screening measure translated into two Ugandan languages. Psychiatry Res Communications. 2021;1(2):100002. doi:10.1016/j.psycom.2021.100002
  • Muramatsu K, Miyaoka H, Kamijima K, et al. Performance of the Japanese version of the patient health questionnaire-9 (J-PHQ-9) for depression in primary care. Gen Hosp Psychiatry. 2018;52:64–69. doi:10.1016/j.genhosppsych.2018.03.007
  • Sawaya H, Atoui M, Hamadeh A, Zeinoun P, Nahas Z. Adaptation and initial validation of the patient health questionnaire–9 (PHQ-9) and the generalized anxiety disorder–7 questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry Res. 2016;239:245–252. doi:10.1016/j.psychres.2016.03.030
  • Wang W, Bian Q, Zhao Y, et al. Reliability and validity of the Chinese version of the patient health questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2014;36(5):539–544. doi:10.1016/j.genhosppsych.2014.05.021
  • Woldetensay YK, Belachew T, Tesfaye M, et al. Validation of the patient health questionnaire (PHQ-9) as a screening tool for depression in pregnant women: afaan oromo version. PLoS One. 2018;13(2):e0191782. doi:10.1371/journal.pone.0191782
  • Reilly TJ, MacGillivray SA, Reid IC, Cameron IM. Psychometric properties of the 16-item quick inventory of depressive Symptomatology: a systematic review and meta-analysis. J Psychiatr Res. 2015;60:132–140. doi:10.1016/j.jpsychires.2014.09.008
  • Trivedi MH, Rush AJ, Ibrahim HM, et al. The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34(1):73–82. doi:10.1017/s0033291703001107
  • De La Garza N, John Rush A, Grannemann BD, Trivedi MH. Toward a very brief self-report to assess the core symptoms of depression (VQIDS-SR(5)). Acta Psychiatr Scand. 2017;135(6):548–553. doi:10.1111/acps.12720
  • Sung SC, Low CCH, Fung DSS, Chan YH. Screening for major and minor depression in a multiethnic sample of A sian primary care patients: a comparison of the nine‐item patient health questionnaire (PHQ‐9) and the 16‐item quick inventory of depressive symptomatology–self‐report (QIDS‐SR16). Asia-Pacific Psychiatry. 2013;5(4):249–258. doi:10.1111/appy.12101
  • Ma S, Yang J, Yang B, et al. The patient health questionnaire-9 vs. the Hamilton rating scale for depression in assessing major depressive disorder. Front Psychiatry. 2021;12:747139. doi:10.3389/fpsyt.2021.74713
  • Hawley CJ, Gale TM, Smith PS, et al. Equations for converting scores between depression scales (MÅDRS, SRS, PHQ-9 and BDI-II): good statistical, but weak idiographic, validity. Hum Psychopharmacol. 2013;28(6):544–551. doi:10.1002/hup.2341
  • Patel R, Wee SN, Ramaswamy R, et al. NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data. BMJ Open. 2022;12(4):e057227. doi:10.1136/bmjopen-2021-057227
  • Bernstein IH, Rush AJ, Carmody TJ, Woo A, Trivedi MH. Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. J Psychiatr Res. 2007;41(3):239–246. doi:10.1016/j.jpsychires.2006.04.001
  • Rush AJ, Madia ND, Carmody T, Trivedi MH. Psychometric and clinical evaluation of the clinician (vqids-c(5)) and self-report (vqids-sr(5)) versions of the very quick inventory of depressive symptoms. Neuropsychiatr Dis Treat. 2022;18:289–302. doi:10.2147/ndt.S342457
  • Kyle PR, Lemming OM, Timmerby N, Søndergaard S, Andreasson K, Bech P. The validity of the different versions of the Hamilton depression scale in separating remission rates of placebo and antidepressants in clinical trials of major depression. J Clin Psychopharmacol. 2016;36(5):453–456. doi:10.1097/jcp.0000000000000557
  • Huang X-J, Ma H-Y, Wang X-M, Zhong J, Sheng D-F, Xu M-Z. Equating the PHQ-9 and GAD-7 to the hads depression and anxiety subscales in patients with major depressive disorder. J Affective Disorders. 2022;311:327–335. doi:10.1016/j.jad.2022.05.079
  • Velozo CA, Byers KL, Wang Y-C, Joseph BR. Translating measures across the continuum of care: using rasch analysis to create a crosswalk between the functional independence measure and the minimum data set. J Rehabil Res Dev. 2007;44(3):467. doi:10.1682/JRRD.2006.06.0068
  • Toland MD. Practical guide to conducting an item response theory analysis. J Early Adolesc. 2013;34(1):120–151. doi:10.1177/0272431613511332
  • Humphreys LG, Montanelli RG. An investigation of the parallel analysis criterion for determining the number of common factors. Multivar Behav Res. 1975;10(2):193–205. doi:10.1207/s15327906mbr1002_5
  • Samejima F. Graded Response Model of the Latent Trait Theory and Tailored Testing. Washington DC: US Government Printing Office; 1976:5–17.
  • Orlando M, Sherbourne CD, Thissen D. Summed-Score Linking Using Item Response Theory: Application to Depression Measurement. US: American Psychological Association; 2000:354–359.
  • Thissen D, Pommerich M, Billeaud K, Williams VS. Item response theory for scores on tests including polytomous items with ordered responses. Appl Psychol Meas. 1995;19(1):39–49. doi:10.1177/014662169501900105
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. doi:10.2307/2529310
  • US Department of Health and Human Services. Health information privacy. Available from: https://www.hhs.gov/hipaa/index.html. Accessed October 11, 2023
  • Feng Y, Huang W, Tian TF, et al. The psychometric properties of the quick inventory of depressive symptomatology-self-report (QIDS-SR) and the Patient health questionnaire-9 (PHQ-9) in depressed inpatients in China. Psychiatry Res. 2016;243:92–96. doi:10.1016/j.psychres.2016.06.021
  • Nandy K, Rush AJ, Carmody T. Reducing the clinical-research gap: a comparison of depressive symptom self-reported measures in psychiatric outpatient youth. J Clin Psych. 2023;85. doi:10.4088/JCP.23m14861
  • Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000;157(12):1925–1932. doi:10.1176/appi.ajp.157.12.1925
  • Fergusson DM, Woodward LJ, Horwood LJ. Risk factors and life processes associated with the onset of suicidal behaviour during adolescence and early adulthood. Psychol Med. 2000;30(1):23–39. doi:10.1017/s003329179900135x
  • Parker G. Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatr Scand. 2007;115(s433):21–30. doi:10.1111/j.1600-0447.2007.00959.x
  • Parker G, Bassett D, Outhred T, et al. Defining melancholia: a core mood disorder. Bipolar Disorders. 2017;19(3):235–237. doi:10.1111/bdi.12501
  • Dorans NJ. Linking scores from multiple health outcome instruments. Qual Life Res. 2007;16:85–94. doi:10.1007/s11136-006-9155-3
  • Bradley JV. Complete counterbalancing of immediate sequential effects in a Latin square design. J Am Stat Assoc. 1958;53(282):525–528. doi:10.1080/01621459.1958.10501456
  • Leucht S, Rothe P, Davis JM, Engel RR. Equipercentile linking of the BPRS and the PANSS. Eur Neuropsychopharmacol. 2013;23(8):956–959. doi:10.1016/j.euroneuro.2012.11.004
  • Sakurai H, Suzuki T, Yoshimura K, Mimura M, Uchida H. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. Psychopharmacology. 2017;234(16):2453–2461. doi:10.1007/s00213-017-4634-5
  • Zimmerman M, Martinez JA, Attiullah N, et al. Why do some depressed outpatients who are in remission according to the Hamilton depression rating scale not consider themselves to be in remission? J Clin Psychiatry. 2012;73(6):790–795. doi:10.4088/JCP.11m07203
  • Tada M, Uchida H, Suzuki T, Abe T, Pollock BG, Mimura M. Baseline difference between patients’ and clinicians’ rated illness severity scores and subsequent outcomes in major depressive disorder: analysis of the sequenced treatment alternatives to relieve depression data. J Clin Psychopharmacol. 2014;34(3):297–302. doi:10.1097/JCP.0000000000000112